<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Wednesday March 6th 2024 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2024-03-06" ></link>
<id>urn:uuid:015f4958-5f12-97d6-9d09-43e52522ea0a</id>
<updated>2026-06-13T10:42:57-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ALLO: PARKER GEOFFREY M (CFO) Bought (B) 190 Shares of ALLOGENE THERAPEUTICS INC for $3.60 on 1/30</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-5955889" ></link>
<id>urn:uuid:1877333b-4bd2-1796-04f9-ff6dfe1b9c64</id>
<updated>2024-03-06T21:52:06-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $1.90. Mkt Cap:655.8mm. 10D Vol: 8.0mm]]></summary>
</entry>
<entry>
<title>ADPT: PELLINI MICHAEL J (DIR) Acquired (JB) 31,328 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955767" ></link>
<id>urn:uuid:5007c5a5-28b4-db67-5fb0-0bb5670b11b9</id>
<updated>2024-03-06T19:46:07-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: OWEN KATEY EINTERZ (DIR) Acquired (JB) 31,328 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955768" ></link>
<id>urn:uuid:3aa3dab5-8b87-7b30-f8e7-4013ec80c94e</id>
<updated>2024-03-06T19:45:53-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: NEUPERT PETER M (DIR) Acquired (JB) 31,328 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955763" ></link>
<id>urn:uuid:141f0921-a544-8464-7303-bd496bbf8cbf</id>
<updated>2024-03-06T19:45:23-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: HERSHBERG ROBERT (DIR) Acquired (JB) 31,328 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955764" ></link>
<id>urn:uuid:458d5ef1-eef5-9722-46fd-71194f749bfe</id>
<updated>2024-03-06T19:45:02-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: GRIFFIN MICHELLE RENEE (DIR) Acquired (JB) 31,328 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955762" ></link>
<id>urn:uuid:a655faa0-8637-a5b4-6195-37eca7033558</id>
<updated>2024-03-06T19:43:59-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: PISKEL KYLE (AO) Acquired (JB) 43,740 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955755" ></link>
<id>urn:uuid:7d234a48-2301-fdbc-69a6-d7e7ed9d0f80</id>
<updated>2024-03-06T19:43:33-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: PISKEL KYLE (AO) Sold (S) 7,727 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $3.43 on 3/5</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955756" ></link>
<id>urn:uuid:acf4252e-0c6c-b9fb-185d-caaf25596ab7</id>
<updated>2024-03-06T19:43:33-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: TAYLOR STACY L (VP,GC) Acquired (JB) 39,990 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $0.00 on 3/4</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955759" ></link>
<id>urn:uuid:a65f35e6-45c5-2bdb-a435-7de6e89c1d81</id>
<updated>2024-03-06T19:42:58-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
<entry>
<title>ADPT: TAYLOR STACY L (VP,GC) Sold (S) 13,381 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $3.43-$3.44 on 3/5</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-5955760" ></link>
<id>urn:uuid:af23c3a9-5304-1d5f-e446-207eb9586ec0</id>
<updated>2024-03-06T19:42:58-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $17.60. Mkt Cap:2.8B. 10D Vol: 2.7mm]]></summary>
</entry>
</feed>